Quantcast Dong-A Pharmtech Co., Ltd. Announces Start Of Phase III Trials For Udenafil, Its - Congoo
 
 
WORLD Log In
Dong-A PharmTech Co., Ltd. Announces Start of Phase III Trials for Udenafil, Its
Have an interest in this Story?
Sign Up for Real-Time email updates
Red Orbit  | November 04, 2009

SEOUL, Korea, Nov. 4 /PRNewswire/ -- Dong-A PharmTech Co. Ltd., announced that its U.S. partner, Warner Chilcott plc, has initiated two, phase III trials for udenafil, a new long acting drug under development for erectile dysfunction (ED). Each randomized, double-blind, placebo-controlled trial is d...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
THENNY MEJIA THENNY MEJIA
Sr. Vice President
Healthcare Industry
Gordon Kauer Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.